Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Brynjelsen Sean
Over the trailing 90 days, Brynjelsen Sean (Director at Eton Pharmaceuticals, Inc.) traded $4.1M of stock (net selling $3.6M) in ETON, per 6 SEC Form 4 transactions.
- Role
- Director
- Companies
- ETON
- Window
- Trailing 90 days · 6 transactions · CIK 1669976
- Net activity
- −$3.6M ($274K bought · $3.8M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | 6 | $274K | $3.8M | −$3.6M |
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-14 | ETON | Buy | 200.0K | $0 | Exercise or conversion of derivative security |
| 2026-07-14 | ETON | Buy | 200.0K | $274K | Exercise or conversion of derivative security |
| 2026-07-12 | ETON | Sell | 27.5K | $0 | Exercise or conversion of derivative security |
| 2026-07-12 | ETON | Buy | 27.5K | $0 | Exercise or conversion of derivative security |
| 2026-05-28 | ETON | Sell | 119.9K | $3.8M | Open market or private sale |
| 2026-05-28 | ETON | Sell | 148 | $5K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Brynjelsen's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.